Comparison of four basic models of indirect pharmacodynamic responses

Journal of Pharmacokinetics and Biopharmaceutics

Volumn 21, Issue 4, 1993, Pages 457-478

  Dayneka, Natalie L ^a,b   Garg, Varun ^a   Jusko, William J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

effect compartment model; indirect response; methylprednisolone; pharmacodynamics; sigmoid Emax model

Indexed keywords

METHYLPREDNISOLONE;

ARTICLE; COMPARTMENT MODEL; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; THEORETICAL STUDY;

COMPARATIVE STUDY; HUMAN; INFUSIONS, INTRAVENOUS; METHYLPREDNISOLONE; MODELS, THEORETICAL; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027769745     PISSN: 0090466X     EISSN: 15738744     Source Type: Journal    
DOI: 10.1007/BF01061691     Document Type: Article

References (23)

1. Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models
2. Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine
3. Semiparametric approach to pharmacokinetic-pharmacodynamic data
4. Pharmacokinetic and pharmacodynamic modeling in vivo
5. Kinetics of pharmacologie effects in man: The anticoagulant action of warfarin
6. Evaluation of a computer-assisted method for individualized anticoagulation: Retrospective and prospective studies with a pharmacodynamic model
7. Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects
8. Two-compartment basophil cell trafficking model for methylprednisolone pharmacodynamics
9. Pharmacoimmunodynamics of methylprednisolone: Trafficking of helper T lymphocytes
10. Mathematical model for in vivo pharmacodynamics integrating fluctuation of the response: Application to the prolactin suppressant effect of the dopaminomimetic drug DCN 203-922
11. Corticosteroid pharmacodynamic modeling: Osteocalcin suppression by prednisolone
12. Receptor-mediated pharmacodynamics of prednisolone in the rat
13. Pharmacokinetic-pharmacodynamic modeling of prednisolone-induced lymphocytopenia in man
14. Pharmacodynamics of methylprednisolone phosphate after single intravenous administration to healthy volunteers
15. Modeling the pharmacokinetics and pharmacodynamics of dexamethasone in depressed patients
16. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists—relationship between intrinsic potency and effective plasma concentrations
17. Dynamics of tolbutamide, glucose, and insulin: Interrelationships following varying doses of intravenous tolbutamide in normal subjects
18. Angiotensin-converting enzyme inhibitors: relationship between pharmacodynamics and pharmacokinetics
19. Red blood cell sorbitol lowering effects and tolerance of single doses of AL 1576 (HOE 843) in diabetic patients
20. Remoxipride: pharmacokinetics and effect on plasma prolactin
21. Diuretic effect and diuretic efficiency after intravenous dosage of frusemide